The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 11, 2015

Filed:

Sep. 30, 2010
Applicants:

Timothy Hla, Avon, CT (US);

Teresa Sanchez, West Hartford, CT (US);

Kevin Patrick Claffey, Burlington, CT (US);

Ji-hye Paik, New Britain, CT (US);

Inventors:

Timothy Hla, Avon, CT (US);

Teresa Sanchez, West Hartford, CT (US);

Kevin Patrick Claffey, Burlington, CT (US);

Ji-Hye Paik, New Britain, CT (US);

Assignee:

THE UNIVERSITY OF CONNECTICUT, Farmington, CT (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/133 (2006.01); A61K 31/137 (2006.01); A61K 31/00 (2006.01); A61K 31/661 (2006.01);
U.S. Cl.
CPC ...
A61K 31/133 (2013.01); A61K 31/00 (2013.01); A61K 31/137 (2013.01); A61K 31/661 (2013.01);
Abstract

Agonists of vascular endothelial sphingosine-1-phosphate receptors are described. Compounds such as FTY720 can be phosphorylated by sphingosine kinase-2 into the phosphorylated forms which serve as sphingosine-1-phosphate receptor agonists. The vascular endothelial sphingosine-1-phosphate receptor agonists are employed in methods of treating a mammal for vascular permeability disorders and unwanted vascular endothelial cell apoptosis, and for the growth of new blood vessels. The sphingosine-1-phosphate receptor agonists can be used for the manufacture of a medicament for treating vascular permeability disorders and unwanted vascular endothelial cell apoptosis, and for the growth of new blood vessels.


Find Patent Forward Citations

Loading…